Atlas Trials

Therapeutic Response to Tumor Necrosis Factor-alpha (TNF-alpha) Antagonists in Rheumatoid Arthritis.

Clinical trial NCT05379049 · UNKNOWN

Trial details

NCT number
NCT05379049
Sponsor
University of Sulaimani
Status
UNKNOWN
Study type
OBSERVATIONAL
Rheumatoid ArthritisInflammatory ArthritisAnkylosing Spondylitis
Start date
2022-03-01
Primary completion
2022-08-31
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.